Due to prolonged isolation and financial difficulties due to lockdown-induced job losses, depression is bearing down on many people across the world. This has got doctors worried about a potential mental health pandemic sweeping across the globe. To keep suicidal thoughts at bay, now, the Food and Drug Administration in the US has approved a quick-acting nasal spray manufactured by Johnson & Johnson which will act as an anti-depressant.